Impact of COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: a possible role of the association to anti-CD20 antibody? A multicentre SEIFEM study

被引：0
|
作者：
Autore, Francesco
Visentin, Andrea
Deodato, Marina
Vitale, Candida
Galli, Eugenio
Fresa, Alberto
Fazzi, Rita
Sanna, Alessandro
Olivieri, Jacopo
Scortechini, Ilaria
del Principe, Maria Ilaria
Sportoletti, Paolo
Schiattone, Luana
Maschio, Nilla
Facchinelli, Davide
Coscia, Marta
Tedeschi, Alessandra
Trentin, Livio
Innocenti, Idanna
Candoni, Anna
Busca, Alessandro
Pagano, Livio
Laurenti, Luca
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1552495
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [31] Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy
    De Oliveira, Antonia
    Lei, Joyce
    Liu, Jiayuan
    Roche, Morgan
    Lin, Jerry
    Alfonso, Roberto
    Sadiq, Saud
    NEUROLOGY, 2023, 100 (17)
  • [32] Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia:: results from a Nordic multicentre study
    Itälä, M
    Geisler, CH
    Kimby, E
    Juvonen, E
    Tjonnfjord, G
    Karlsson, K
    Remes, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (03) : 129 - 134
  • [33] Activity and Safety of Venetoclax without Anti-CD20 Lead-in Therapy in Treatment Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia
    Pleyer, Christopher
    Tomasulo, Emily
    Superata, Jeanine
    Adams, Rachel
    Tian, Xin
    Grey, Jayson
    Nierman, Pia
    Wiestner, Adrian
    Sun, Clare
    BLOOD, 2024, 144 : 4623 - 4623
  • [34] Cytokine release in patients treated with obinutuzumab, a glycoengineered type II anti-CD20 antibody and possible relationship with development of infusion related reactions in patients with chronic lymphocytic leukaemia
    Freeman, C.
    Morschhauser, F.
    Fingerle-Rowson, G.
    Lei, G.
    Wassner-Fritsch, E.
    Cartron, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 70 - 70
  • [35] Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
    Adamo, Francesco Maria
    Barcelos, Estevao Carlos Silva
    De Falco, Filomena
    Dorillo, Erica
    Rompietti, Chiara
    Sorcini, Daniele
    Stella, Arianna
    Del Papa, Beatrice
    Baldoni, Stefano
    Esposito, Angela
    Geraci, Clelia
    Arcaleni, Roberta
    Pennetta, Chiara
    Ragonese, Francesco
    Moretti, Lorenzo
    Mameli, Mariagrazia
    Di Ianni, Mauro
    Rosati, Emanuela
    Fioretti, Bernard
    Sportoletti, Paolo
    CANCERS, 2023, 15 (14)
  • [36] Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody
    Grajales-Cruz, Ariel F.
    Chavez, Julio
    Volpe, Virginia Olivia
    Sandoval-Sus, Jose
    Shah, Bijal
    Bello, Celeste
    Sokol, Lubomir
    Fisher, Shanel
    Nair, Rajesh R.
    Seongseok, Yun
    Saeed, Hayder
    Isenalumhe, Leidy
    Turba, Elyce P.
    Nodzon, Lisa
    Ibarz, Javier Pinilla
    BLOOD, 2019, 134
  • [37] COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study
    Kochneva, Olga L.
    Kislova, Maria
    Zhelnova, Evgenya, I
    Petrenko, Andrei A.
    Baryakh, Elena A.
    Yatskov, Konstantin, V
    Dmitrieva, Elena A.
    Misurina, Elena N.
    Nikitin, Konstantin E.
    Vasilieva, Elena J.
    Samsonova, Inna, V
    Ptushkin, Vadim V.
    Baranova, Ancha
    Nikitin, Eugene A.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1607 - 1616
  • [38] Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19
    Wilber, Eli
    Piantadosi, Anne
    Babiker, Ahmed
    McLendon, Kaleb
    O'Sick, William
    Fitts, Eric
    Webster, Andrew S.
    Verkerke, Hans
    Kim, James S.
    Phadke, Varun K.
    Rouphael, Nadine
    Titanji, Boghuma K.
    Blake, William T.
    Howard-Anderson, Jessica
    Roback, John D.
    Lam, Wilbur A.
    Damhorst, Gregory L.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (08):
  • [39] COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
    Meca-Lallana, Virginia
    Aguirre, Clara
    Rio, Beatrizdel
    Cardenoso, Laura
    Alarcon, Teresa
    Vivancos, Jose
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [40] Longitudinal COVID-19 immune trajectories in autoimmune patients on anti-CD20 therapy
    Bazzi, S.
    Maguire, C.
    Holay, N.
    Geltman, J.
    Hurley, K.
    Ehrlich, L.
    Triplett, T.
    Melamed, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 230 - 230
12345